Indication
Pancoast Tumor
1 clinical trial
3 drugs
Clinical trial
Phase II Clinical Trial of Neo-adjuvant Chemo/Immunotherapy Followed by Adjuvant Treatment Depending on the Resection Status for the Treatment of NSCLC Patients Diagnosed With Pancoast Tumor. A Multicenter Exploratory StudyStatus: Recruiting, Estimated PCD: 2028-03-01
Drug
AN0025Drug
TiragolumabDrug
T-VEC